BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17675877)

  • 1. Fanconi anemia: genetic analysis of a human disease using chicken system.
    Takata M; Kitao H; Ishiai M
    Cytogenet Genome Res; 2007; 117(1-4):346-51. PubMed ID: 17675877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fanconi anemia pathway: insights from somatic cell genetics using DT40 cell line.
    Takata M; Ishiai M; Kitao H
    Mutat Res; 2009 Jul; 668(1-2):92-102. PubMed ID: 19622405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
    Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
    DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination.
    Yamamoto K; Hirano S; Ishiai M; Morishima K; Kitao H; Namikoshi K; Kimura M; Matsushita N; Arakawa H; Buerstedde JM; Komatsu K; Thompson LH; Takata M
    Mol Cell Biol; 2005 Jan; 25(1):34-43. PubMed ID: 15601828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia.
    Smith J; Andrau JC; Kallenbach S; Laquerbe A; Doyen N; Papadopoulo D
    J Mol Biol; 1998 Sep; 281(5):815-25. PubMed ID: 9719637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1.
    Godthelp BC; Artwert F; Joenje H; Zdzienicka MZ
    Oncogene; 2002 Jul; 21(32):5002-5. PubMed ID: 12118380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of homologous recombinational repair in chicken B lymphoma cell line, DT40.
    Kitao H; Hirano S; Takata M
    Methods Mol Biol; 2011; 745():293-309. PubMed ID: 21660701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
    Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
    Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate DNA repair activity associated with the 322delG allele of the fanconi anemia complementation group C gene.
    Donahue SL; Lundberg R; Campbell C
    J Mol Biol; 2004 Oct; 342(5):1443-55. PubMed ID: 15364573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis.
    Kawamoto T; Araki K; Sonoda E; Yamashita YM; Harada K; Kikuchi K; Masutani C; Hanaoka F; Nozaki K; Hashimoto N; Takeda S
    Mol Cell; 2005 Dec; 20(5):793-9. PubMed ID: 16337602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
    Dunn J; Potter M; Rees A; Rünger TM
    Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complex role of the FA proteins in providing genome stability].
    Kluzek K; Zdzienicka MZ
    Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
    Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
    Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
    Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
    Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fanconi Anemia/BRCA pathway: new faces in the crowd.
    Kennedy RD; D'Andrea AD
    Genes Dev; 2005 Dec; 19(24):2925-40. PubMed ID: 16357213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.